STAT2 contributes to promotion of colorectal and skin carcinogenesis

Cancer Prevention Research

Volumn 3, Issue 4, 2010, Pages 495-504

  Gamero, Ana M ^a   Young, Matthew R ^b   Mentor Marcel, Roycelynn ^b   Bobe, Gerd ^b   Scarzello, Anthony J ^a   Wise, Jennifer ^b   Colburn, Nancy H ^b  

^a Cancer and Inflammation Program   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; AZOXYMETHANE; DEXTRAN SULFATE; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; PHORBOL 13 ACETATE 12 MYRISTATE; STAT2 PROTEIN;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CARCINOMA CELL; CHRONIC INFLAMMATION; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; IMMUNE RESPONSE; MEDIATOR; MOUSE; NONHUMAN; POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN CARCINOMA; SURVIVAL;

ANIMALS; CARCINOGENS; CELL TRANSFORMATION, NEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; STAT2 TRANSCRIPTION FACTOR;

EID: 77950799520     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0105     Document Type: Article

References (41)

1. Balkwill F, Charles KA, Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005;7:211-217
2. Ekbom A. Risk of cancer in ulcerative colitis. J Gastrointest Surg 1998;2:312-313
3. Xiao H, Gulen MF, Qin J, et al. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 2007;26:461-475
4. Greten FR, Eckmann L, Greten TF, et al. IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004;118:285-296
5. Pikarsky E, Porat RM, Stein I, et al. NF-κB functions as a tumour promoter in inflammation-associated cancer. Nature 2004;431: 461-466
6. Garlanda C, Riva F, Veliz T, et al. Increased susceptibility to colitisassociated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res 2007;67:6017-6021
7. Becker C, Fantini MC, Wirtz S, et al. IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle 2005;4:217-220
8. Krelin Y, Voronov E, Dotan S, et al. Interleukin-1β-driven inflammation promotes the development and invasiveness of chemical carcinogen-induced tumors. Cancer Res 2007;67:1062-1071
9. Popivanova BK, Kitamura K, Wu Y, et al. Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008;118:560-570
10. Hanada T, Kobayashi T, Chinen T, et al. IFNγ-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. J Exp Med 2006;203:1391-1397
11. Moore RJ, Owens DM, Stamp G, et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis. Nat Med 1999;5:828-831
12. Reiners JJ, Jr., Rupp T, Colby A, Cantu AR, Pavone A. Tumor copromoting activity of γ-interferon in the murine skin multistage carcinogenesis model. Cancer Res 1989;49:1202-1206
13. Ito R, Shin-Ya M, Kishida T, et al. Interferon-γ is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol 2006;146:330-338
14. Katakura K, Lee J, Rachmilewitz D, Li G, Eckmann L, Raz E. Toll-like receptor 9-induced type I IFN protects mice from experimental colitis. J Clin Invest 2005;115:695-702.
15. Nikolaus S, Rutgeerts P, Fedorak R, et al. Interferon β-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study. Gut 2003;52:1286-1290 (Pubitemid 37026460)
16. Leung S, Qureshi SA, Kerr IM, Darnell JE, Jr., Stark GR. Role of STAT2 in the α interferon signaling pathway. Mol Cell Biol 1995;15: 1312-1317
17. Rawlings JS, Rosler KM, Harrison DA. The JAK/STAT signaling pathway. J Cell Sci 2004;117:1281-1283
18. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998;67:227-264
19. Qureshi SA, Leung S, Kerr IM, Stark GR, Darnell JE, Jr. Function of Stat2 protein in transcriptional activation by α interferon. Mol Cell Biol 1996;16:288-293
20. Gamero AM, Larner AC. Vanadate facilitates interferon α-mediated apoptosis that is dependent on the Jak/Stat pathway. J Biol Chem 2001;276:13547-13553
21. Clifford JL, Yang X, Walch E, Wang M, Lippman SM. Dominant negative signal transducer and activator of transcription 2 (STAT2) protein: stable expression blocks interferon α action in skin squamous cell carcinoma cells. Mol Cancer Ther 2003;2:453-459
22. Wang J, Pham-Mitchell N, Schindler C, Campbell IL. Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-α-stimulated STAT2-independent production of IFN-γ in the brain. J Clin Invest 2003;112:535-543
23. Mudter J, Weigmann B, Bartsch B, et al. Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am J Gastroenterol 2005;100:64-72.
24. Park C, Li S, Cha E, Schindler C. Immune response in Stat2 knockout mice. Immunity 2000;13:795-804.
25. Boivin GP, Washington K, Yang K, et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003;124:762-777
26. Herlyn M, Herlyn D, Elder DE, et al. Phenotypic characteristics of cells derived from precursors of human melanoma. Cancer Res 1983;43:5502-5508
27. Rosenberg DW, Giardina C, Tanaka T. Mouse models for the study of colon carcinogenesis. 2009:183-196
28. Ancrile B, Lim KH, Counter CM. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 2007;21:1714-1719
29. Abate-Shen C, Brown PH, Colburn NH, et al. The untapped potential of genetically engineered mouse models in chemoprevention research: opportunities and challenges. Cancer Prev Res 2008;1: 161-166
30. Young MR, Li JJ, Rincon M, et al. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc Natl Acad Sci U S A 1999;96:9827-9832
31. Young MR, Yang HS, Colburn NH. Promising molecular targets for cancer prevention: AP-1, NF-κB and Pdcd4. Trends Mol Med 2003;9: 36-41.
32. Matthews CP, Birkholz AM, Baker AR, et al. Dominant-negative activator protein 1 (TAM67) targets cyclooxygenase-2 and osteopontin under conditions in which it specifically inhibits tumorigenesis. Cancer Res 2007;67:2430-2438
33. Wei Q, Jiang H, Matthews CP, Colburn NH. Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. Proc Natl Acad Sci U S A 2008;105:19738-19743
34. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420: 860-867
35. Grivennikov S, Karin E, Terzic J, et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitisassociated cancer. Cancer Cell 2009;15:103-113
36. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007;117:1175-1183
37. Clifford JL, Walch E, Yang X, et al. Suppression of type I interferon signaling proteins is an early event in squamous skin carcinogenesis. Clin Cancer Res 2002;8:2067-2072
38. Gimeno R, Lee CK, Schindler C, Levy DE. Stat1 and Stat2 but not Stat3 arbitrate contradictory growth signals elicited by α/β interferon in T lymphocytes. Mol Cell Biol 2005;25:5456-5465
39. Chan KS, Sano S, Kiguchi K, et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest 2004;114:720-728
40. Aalinkeel R, Hu Z, Nair BB, et al. Genomic analysis highlights the role of the JAK-STAT signaling in the anti-proliferative effects of dietary flavonoid 'Ashwagandha' in prostate cancer cells. Evid Based Complement Alternat Med. Epub 2008 Jan 10.
41. Stancato LF, David M, Carter-Su C, Larner AC, Pratt WB. Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. J Biol Chem 1996;271:4134-4137